0001638599-21-000563.txt : 20210617 0001638599-21-000563.hdr.sgml : 20210617 20210617092126 ACCESSION NUMBER: 0001638599-21-000563 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210616 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clasby Jennifer G CENTRAL INDEX KEY: 0001728919 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38365 FILM NUMBER: 211023517 MAIL ADDRESS: STREET 1: 501 FIFTH AVENUE STREET 2: SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EYENOVIA, INC. CENTRAL INDEX KEY: 0001682639 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 471178401 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 295 MADISON AVENUE, STREET 2: SUITE 2400 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 813-766-9539 MAIL ADDRESS: STREET 1: 295 MADISON AVENUE, STREET 2: SUITE 2400 CITY: NEW YORK STATE: NY ZIP: 10017 4 1 doc4_7271.xml PRIMARY DOCUMENT X0306 4 2021-06-16 0 0001682639 EYENOVIA, INC. EYEN 0001728919 Clasby Jennifer G C/O EYENOVIA, INC. 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 0 1 0 0 VP, Regulatory and Clinical Stock Option (right to buy) 6.01 2021-06-16 4 A 0 128258 6.01 A 2021-06-16 Common Stock 128258 128258 D 1. This stock option was granted by the Issuer's Board of Directors on January 30, 2021, subject to stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the amendment to the Plan on June 16, 2021. One-third of the option becomes exercisable on January 30, 2022 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. /s/ Jennifer Clasby 2021-06-17